Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05222594 · ClinicalTrials.gov registry record · NA

Computational Neuroscience of Language Processing in the Human Brain

A NA study of Epilepsy and Language, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05222594 is a NA study of Epilepsy and Language that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05222594, a NA study of Epilepsy and Language, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Language is a signature human cognitive skill, but the precise computations that support language understanding remain unknown. This study aims to combine high-quality human neural data obtained through intracranial recordings with advances in computational modeling of human cognition to shed light on the construction and understanding of speech.

Conditions Studied

Interventions

  • OTHER Behavioral tasks during intracranial monitoring

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-04-02
Est. Completion 2026-03-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05222594

The ClinicalTrials.gov registry entry for NCT05222594 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Behavioral tasks during intracranial monitoring is the first listed.

NCT05222594 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05222594 about?

NCT05222594 is a clinical study titled "Computational Neuroscience of Language Processing in the Human Brain". Language is a signature human cognitive skill, but the precise computations that support language understanding remain unknown. This study aims to combine high-quality human neural data obtained through intracranial recordings with advances in computational modeling of human cognition to shed light ...

What is the current status of trial NCT05222594?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-04-02. Estimated completion is 2026-03-31.

What conditions does trial NCT05222594 study?

This clinical trial studies the following conditions: Epilepsy, Language.

What interventions are being tested in trial NCT05222594?

The interventions under investigation include: Behavioral tasks during intracranial monitoring (OTHER).

Who is sponsoring clinical trial NCT05222594?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05222594 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.